Accounts Payable, Current of EUPRAXIA PHARMACEUTICALS INC. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary: EUPRAXIA PHARMACEUTICALS INC. quarterly Accounts Payable, Current in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
EUPRAXIA PHARMACEUTICALS INC. Accounts Payable, Current for the quarter ending 31 Dec 2025 was $942,201, a 150% increase year-over-year.
Source SEC data: View on sec.gov

Accounts Payable, Current, Quarterly (USD)

Accounts Payable, Current, YoY Quarterly Change (%)

EUPRAXIA PHARMACEUTICALS INC. Quarterly Accounts Payable, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$942,201	+$565,660	+150%	31 Dec 2025	40-F	13 Mar 2026	2025	FY
Q4 2024	$376,541	-$915,587	-71%	31 Dec 2024	40-F	13 Mar 2026	2025	FY
Q4 2023	$1,292,128	-$521,939	-29%	31 Dec 2023	40-F	20 Mar 2025	2024	FY
Q4 2022	$1,814,067			31 Dec 2022	40-F	01 Apr 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.